Latest news
Replimune Group, Inc. (REPL) Shareholder/Analyst Call - Slideshow (NASDAQ:REPL) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 10:32:36 GMTReplimune stock upgraded at Cantor on FDA vote (REPL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTReplimune surges on positive AdCom vote on lead drug - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTReplimune: 'Sell' Continued Doubt On Single-Arm IGNYTE Trial For RP1 FDA Review (REPL) - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTReplimune joins Capricor in post-briefing doc sell-off - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMT